Login / Signup

Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017.

Giulia BonaldoAlberto VaccheriOttavio D'AnnibaliDomenico Motola
Published in: British journal of clinical pharmacology (2019)
The AEFI analysis showed that the events most frequently reported were non-serious and listed in the corresponding summary of product characteristics. Potential safety signals arose regarding less frequent AEFIs that would deserve further investigation. It is extremely important to disseminate correct and evidence-based scientific information.
Keyphrases
  • endothelial cells
  • adverse drug
  • induced pluripotent stem cells
  • healthcare
  • emergency department
  • health information
  • risk assessment
  • climate change
  • electronic health record